NDLI: Sublethal Injury and Resuscitation of Candida albicans after Amphotericin B Treatment

Content Provider	PubMed Central
Author	Liao, Robert S. Rennie, Robert P. Talbot, James A.
Copyright Year	2003
Abstract	Amphotericin B treatment was previously shown to inhibit Candida albicans reproduction and reduce the fluorescence of vitality-specific dyes without causing a corresponding increase in the fluorescence of the mortality-specific dyes bis-(1,3-dibutylbarbituric acid)trimethine oxonol and SYBR Green Ι. In the present study, we have confirmed these results and have shown that the numbers of CFU are reduced by 99.9% by treatment with 0.5 μg of amphotericin B per ml for 10 h at 35°C. This reduction was not due to fungal cell death. First, the level of reduction of the tetrazolium salt 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide increased in the presence of concentrations of amphotericin B that caused greater than 90% reductions in the numbers of CFU. Second, fungal cells treated with amphotericin B at a concentration of 0.5 μg/ml were resuscitated by further incubation at 22°C for 15 h in the continued presence of amphotericin B. Third, recovery of the ability to replicate was prevented by sequential treatment with 20 μg of miconazole per ml, which also increased the fluorescence of mortality-specific dyes to near the maximal levels achieved with 0.9 μg of amphotericin B per ml. Sequential treatment with fluconazole and flucytosine did not increase the levels of staining with the mortality-specific dyes. Itraconazole was less effective than ketoconazole, which was less effective than miconazole. The practice of equating the loss of the capacity of C. albicans to form colonies with fungal cell death may give incorrect results in assays with amphotericin B, and the results of assays with caution with other antifungal agents that are lipophilic or that possess significant postantifungal effects may need to be interpreted.
Related Links	http://dx.doi.org/10.1128/AAC.47.4.1200-1206.2003
Starting Page	1200
File Format	PDF
ISSN	10986596
e-ISSN	10986596
Journal	Antimicrobial Agents and Chemotherapy
Issue Number	4
Volume Number	47
Language	English
Publisher	American Society for Microbiology
Publisher Date	2003-04-01
Access Restriction	Open
Rights Holder	American Society for Microbiology
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Infectious Diseases Pharmacology Pharmacology (medical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Comparative Susceptibility of Candida albicans to Amphotericin B and Amphotericin B Methyl Ester

Interaction between Posaconazole and Amphotericin B in Concomitant Treatment against Candida albicans In Vivo

Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.

Liposomal Amphotericin B Displays Rapid Dose-Dependent Activity against Candida albicans Biofilms

Rabbit Model of Candida albicans Biofilm Infection: Liposomal Amphotericin B Antifungal Lock Therapy

In vitro interaction between amphotericin B and azoles in Candida albicans.

Iron-Limited Biofilms of Candida albicans and Their Susceptibility to Amphotericin B

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.

Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.

Sublethal Injury and Resuscitation of Candida albicans after Amphotericin B Treatment

Similar Documents

Comparative Susceptibility of Candida albicans to Amphotericin B and Amphotericin B Methyl Ester

Interaction between Posaconazole and Amphotericin B in Concomitant Treatment against Candida albicans In Vivo

Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.

Liposomal Amphotericin B Displays Rapid Dose-Dependent Activity against Candida albicans Biofilms

Rabbit Model of Candida albicans Biofilm Infection: Liposomal Amphotericin B Antifungal Lock Therapy

In vitro interaction between amphotericin B and azoles in Candida albicans.

Iron-Limited Biofilms of Candida albicans and Their Susceptibility to Amphotericin B

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.

Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.

Sublethal Injury and Resuscitation of Candida albicans after Amphotericin B Treatment